Back to Search
Start Over
Prospects for treatment of latent HIV.
- Source :
-
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2013 Jan; Vol. 93 (1), pp. 46-56. Date of Electronic Publication: 2012 Oct 10. - Publication Year :
- 2013
-
Abstract
- Recent advances in antiretroviral therapy (ART) have drastically improved the quality of life for people with HIV infection. However, owing to the persistence of latent HIV in the presence of therapy, patients must remain on therapy indefinitely. Currently, the solution to the HIV pandemic rests on the prevention of new infections and many decades of ART for the steadily expanding number of people infected worldwide. ART is costly, requires ongoing medical care, and can have side effects, thereby preventing its universal availability. Therefore, to escape the ironic burdens of therapy, efforts have begun to develop treatments for latent HIV infection. Current approaches propose either complete eradication of infection or induction of a state of stringent control over viral replication without ART. This review will discuss these strategies in detail and their potential for clinical development.
- Subjects :
- Anti-Retroviral Agents therapeutic use
Antiretroviral Therapy, Highly Active methods
Clinical Trials as Topic methods
Clinical Trials as Topic trends
HIV Infections epidemiology
HIV Infections genetics
HIV-1 genetics
Humans
Treatment Outcome
Virus Latency genetics
Anti-HIV Agents therapeutic use
Antiretroviral Therapy, Highly Active trends
HIV Infections drug therapy
HIV-1 drug effects
Virus Latency drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1532-6535
- Volume :
- 93
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Clinical pharmacology and therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 23212106
- Full Text :
- https://doi.org/10.1038/clpt.2012.202